GT
INGN icon

Glenmede Trust’s Inogen INGN Stock Holding History

Glenmede Trust’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38,010
Closed -$369K – 1420
2024
Q3 		$369K Hold
38,010
– – ﹤0.01% 1031
2024
Q2 		$309K Sell
38,010
-3,000
-7% -$23.2K ﹤0.01% 1052
2024
Q1 		$331K Hold
41,010
– – ﹤0.01% 1030
2023
Q4 		$225K Buy
41,010
+1,340
+3% +$7.08K ﹤0.01% 1116
2023
Q3 		$207K Buy
39,670
+11,285
+40% +$80.2K ﹤0.01% 1091
2023
Q2 		$354K Hold
28,385
– – ﹤0.01% 934
2023
Q1 		$354K Buy
28,385
+8,592
+43% +$164K ﹤0.01% 939
2022
Q4 		$390K Buy
19,793
+4,864
+33% +$105K ﹤0.01% 902
2022
Q3 		$361K Sell
14,929
-7
-0% -$193 ﹤0.01% 895
2022
Q2 		$360K Sell
14,936
-25
-0.2% -$664 ﹤0.01% 954
2022
Q1 		$484K Buy
14,961
+48
+0.3% +$1.51K ﹤0.01% 901
2021
Q4 		$506K Sell
14,913
-5,604
-27% -$204K ﹤0.01% 922
2021
Q3 		$883K Buy
20,517
+14
+0.1% +$861 ﹤0.01% 741
2021
Q2 		$1.33M Sell
20,503
-41
-0.2% -$2.6K 0.01% 629
2021
Q1 		$1.08M Buy
20,544
+43
+0.2% +$2.15K 0.01% 659
2020
Q4 		$915K Sell
20,501
-85
-0.4% -$2.94K 0.01% 686
2020
Q3 		$596K Buy
20,586
+4,588
+29% +$144K ﹤0.01% 738
2020
Q2 		$568K Buy
15,998
+9,737
+156% +$410K ﹤0.01% 737
2020
Q1 		$426K Hold
6,261
– – ﹤0.01% 952
2019
Q4 		$426K Buy
6,261
+1,252
+25% +$78.5K ﹤0.01% 952
2019
Q3 		$239K Buy
5,009
+3,781
+308% +$197K ﹤0.01% 1099
2019
Q2 		$81K Buy
1,228
+300
+32% +$22.8K ﹤0.01% 1478
2019
Q1 		$87K Buy
928
+900
+3,214% +$112K ﹤0.01% 1456
2018
Q4 		$3K Buy
+28
New +$4.61K ﹤0.01% 2681
2018
Q3 		– Sell
-90
Closed -$17K – 1629
2018
Q2 		$17K Buy
+90
New +$15K ﹤0.01% 1759

Other funds holding INGN

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Glenmede Trust's INGN Position: Q4 2024 in Review

Glenmede Trust sold out of Inogen (INGN) in Q4 2024, closing a stake of 38,010 shares — an estimated $369K sold.

Glenmede Trust first reported a position in INGN in Q2 2018 and held it in 25 quarters. The position peaked at $1.33M in Q2 2021. 136 funds tracked by Wall St. Rank hold INGN as of Q4 2024.

  • Glenmede Trust reported no remaining Inogen position as of Q4 2024 after selling out during the quarter.
  • Glenmede Trust sold 38,010 Inogen shares in Q4 2024, an estimated $369K.
  • Glenmede Trust first reported a position in Inogen in Q2 2018 and held it in 25 quarters.
  • Glenmede Trust's Inogen position peaked at $1.33M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Inogen as of Q4 2024.

Based on Glenmede Trust's 13F filing for Q4 2024, filed 14 Feb 2025.